Split History
ETFs Holding NLTX »    NLTX Historical Stock Prices »



Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Neoleukin Therapeutics is a biopharmaceutical company, focused on immunotherapies for cancer, inflammation, and autoimmunity using de novo protein design technology. Co. is focused on key cytokine mimetics, which Co. refers to as Neoleukin de novo cytokine mimetics, that can be modified to adjust affinity, thermodynamic stability, resistance to biochemical modification, pharmacokinetic characteristics, potency and targeting to tumor or inflamed tissues. Co.'s NL-201 is designed to mimic the therapeutic activity of the cytokines interleukin-2 and interleukin-15 for the potential treatment of various types of cancer, including renal cell carcinoma, melanoma, and hematological malignancies. According to our NLTX split history records, Neurogene has had 2 splits.
NLTX split history picture
Neurogene (NLTX) has 2 splits in our NLTX split history database. The first split for NLTX took place on September 25, 2023. This was a 1 for 5 reverse split, meaning for each 5 shares of NLTX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split. NLTX's second split took place on December 19, 2023. This was a 1 for 4 reverse split, meaning for each 4 shares of NLTX owned pre-split, the shareholder now owned 1 share. For example, a 200 share position pre-split, became a 50 share position following the split.

When a company such as Neurogene conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the NLTX split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Neurogene shares, starting with a $10,000 purchase of NLTX, presented on a split-history-adjusted basis factoring in the complete NLTX split history. NLTX split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/30/2014
End date: 12/19/2023
Start price/share: $182.60
End price/share: $3.49
Dividends collected/share: $0.00
Total return: -98.09%
Average Annual Total Return: -33.66%
Starting investment: $10,000.00
Ending investment: $191.09
Years: 9.64
Date Ratio
09/25/20231 for 5
12/19/20231 for 4
NLTX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

NMRD Split History
NMTR Split History
NNVC Split History
NOVN Split History
NRBO Split History
NRCIB Split History
NSPH Split History
NSPR Split History
NTEC Split History
NTRB Split History

Also explore: NLTX shares outstanding history

Email EnvelopeFree NLTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Gaucho Group Holdings, Inc. (VINO)
STRATA Skin Sciences, Inc. (SSKN)
Society Pass Inc. (SOPA)
Recon Technology, Ltd. (RCON)
iSun, Inc. (ISUN)
Avenue Therapeutics, Inc. (ATXI)
Bakkt Holdings, Inc. (BKKT)
Applied DNA Sciences, Inc. (APDN)
Cidara Therapeutics, Inc. (CDTX)
Smart for Life, Inc. (SMFL)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

NLTX Insider Buying

NLTX Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.